Coherus Oncology (CHRS) Goodwill & Intangibles (2014 - 2026)
Coherus Oncology (CHRS) reported Goodwill & Intangibles of $44.99 million for Q2 2026, down 14.0% from $52.31 million a year earlier and down 1.4% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Goodwill & Intangibles (2014 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology posted Goodwill & Intangibles of $46.24 million, down 13.8% from FY2024.
- Goodwill & Intangibles has a five-year compound annual growth rate of 67.0% (FY2020 to FY2025).
- By year, Goodwill & Intangibles came in at $53.65 million in FY2024 (-25.2%), $71.67 million in FY2023, $5.93 million in FY2022 (+66.5%) and $3.56 million in FY2021 (unchanged).
- The Q2 2026 figure ranks as the lowest quarterly Goodwill & Intangibles since Q2 2023.
- Year over year, Goodwill & Intangibles has now declined in each of the last seven quarters, with an average decline of 9.0% over the last eight quarters.
- The high point for year-over-year Goodwill & Intangibles in five years was Q1 2024 (growth of 872.8%); the low point was Q4 2024 (a decline of 25.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $45.61 million (Q1 2026), $46.24 million (Q4 2025) and $49.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.99 Mn |
| Mar 31, 2026 | 45.61 Mn |
| Dec 31, 2025 | 46.24 Mn |
| Sep 30, 2025 | 49.48 Mn |
| Jun 30, 2025 | 52.31 Mn |
| Mar 31, 2025 | 52.98 Mn |
| Dec 31, 2024 | 53.65 Mn |
| Sep 30, 2024 | 54.31 Mn |
| Jun 30, 2024 | 55.46 Mn |
| Mar 31, 2024 | 57.10 Mn |
| Dec 31, 2023 | 71.67 Mn |
| Sep 30, 2023 | 46.52 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Mar 31, 2023 | 5.87 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 3.56 Mn |
| Mar 31, 2022 | 3.56 Mn |
| Dec 31, 2021 | 3.56 Mn |
| Sep 30, 2021 | 3.56 Mn |
API Access
Coherus Oncology Goodwill & Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "goodwill-and-intangibles", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();